cris.boxmetadata.label.title
Successful Treatment of Primary Amoebic Meningoencephalitis Using a Novel Therapeutic Regimen Including Miltefosine and Voriconazole
cris.boxmetadata.label.dateissued
01 browse.startsWith.months.september 2022
cris.boxmetadata.label.accesslevel
metadata only access
cris.boxmetadata.label.resourcetype
journal article
cris.boxmetadata.label.publisher
Springer Science and Business Media Deutschland GmbH
cris.boxmetadata.label.abstract
The genus Naegleria consists of free-living amoebae widely distributed worldwide in soil and freshwater habitats. Primary amoebic meningoencephalitis (PAM) is an uncommon and most likely fatal disease. The incubation period is approximately 7 days. The first symptoms are headache, nasal congestion, fever, vomiting, stiff neck within 3–4 days after the first symptoms, confusion, abnormal behavior, seizures, loss of balance and body control, coma, and death. We describe the case of a child who presented with PAM due to Naegleria sp., fully recovered from the infection without apparent sequels after treatment with a regimen that included miltefosine and voriconazole.
cris.boxmetadata.label.citationstartpage
1421
cris.boxmetadata.label.citationendpage
1424
cris.boxmetadata.label.volume
67
cris.boxmetadata.label.issue
3
cris.boxmetadata.label.language
English
cris.boxmetadata.label.ocdeknowledgeArea
Pediatría
cris.boxmetadata.label.doi
cris.boxmetadata.label.scopusidentifier
2-s2.0-85134536478
cris.boxmetadata.label.pubmedidentifier
cris.boxmetadata.label.source
Acta Parasitologica
cris.boxmetadata.label.containerissn
12302821
peru-layout.shadow-copies Directorio de Producción Científica Scopus